APA (7th ed.) Citation

Makras, P., Yavropoulou, M. P., Anastasilakis, A. D., Papatheodorou, A., Tekedis, C., & Papapoulos, S. E. (2024). Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis International, 35(4), 741. https://doi.org/10.1007/s00198-023-07000-5

Chicago Style (17th ed.) Citation

Makras, Polyzois, Maria P. Yavropoulou, Athanasios D. Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, and Socrates E. Papapoulos. "Transient Osteoporosis of the Hip Following Discontinuation of Denosumab and Switch to Alendronate Treatment." Osteoporosis International 35, no. 4 (2024): 741. https://doi.org/10.1007/s00198-023-07000-5.

MLA (9th ed.) Citation

Makras, Polyzois, et al. "Transient Osteoporosis of the Hip Following Discontinuation of Denosumab and Switch to Alendronate Treatment." Osteoporosis International, vol. 35, no. 4, 2024, p. 741, https://doi.org/10.1007/s00198-023-07000-5.